<?xml version="1.0" ?>
<tei xml:space="preserve">
	<teiHeader>
		<fileDesc xml:id="Bousquet 2018"/>
	</teiHeader>
	<text xml:lang="en">
		<front>
<lb/>
	Edinburgh
	<note type="doctype">Research Explorer<lb/></note>

	<docTitle>
	<titlePart>The ARIA score of allergic rhinitis using mobile technology<lb/> correlates with quality-of-life<lb/></titlePart>
	</docTitle>

	Citation for published version:<lb/>
	<reference>MASK study group, Bousquet, J, Arnavielhe, S, Bedbrook, A, Fonseca, J, Morais Almeida, M, Todo Bom, A,<lb/> Annesi-Maesano, I, Caimmi, D, Demoly, P, Devillier, P, Siroux, V, Menditto, E, Passalacqua, G, Stellato, C,<lb/> Ventura, MT, Cruz, AA, Serpa, FS, da Silva, J, Larenas-Linnemann, D, Rodriguez Gonzalez, M, Cabañas,<lb/> MTB, Bergmann, KC, Keil, T, Klimek, L, Mösges, R, Shamai, S, Zuberbier, T, Bewick, M, Price, D, Ryan, D,<lb/> Sheikh, A, Anto, JM, Mullol, J, Valero, A, Haahtela, T, Valovirta, E, Fokkens, WJ, Kuna, P, Samolinski, B,<lb/> Bindslev-Jensen, C, Eller, E, Bosnic-Anticevich, S, O&apos;Hehir, RE, Tomazic, PV, Yorgancioglu, A, Gemicioglu,<lb/> B, Bachert, C, Hellings, PW, Kull, I &amp; Melén, E 2017, &apos;The ARIA score of allergic rhinitis using mobile<lb/> technology correlates with quality-of-life: The MASK study&apos;, Allergy.</reference>

	<idno>https://doi.org/10.1111/all.13307<lb/></idno>

	Digital Object Identifier (
	<idno>DOI):<lb/> 10.1111/all.13307<lb/></idno>

	Link:<lb/>
	<note type="submission">Link to publication record in Edinburgh Research Explorer<lb/> Document Version:<lb/> Peer reviewed version<lb/></note>

	Published In: Allergy<lb/> General rights<lb/>
	<note type="copyright">Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)<lb/> and / or other copyright owners and it is a condition of accessing these publications that users recognise and<lb/> abide by the legal requirements associated with these rights.<lb/> Take down policy<lb/> The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer<lb/> content complies with UK legislation. If you believe that the public display of this file breaches copyright please<lb/> contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and<lb/> investigate your claim.<lb/></note>

	<note type="submission">Download date: 10. Jun. 2022<lb/> Accepted Article<lb/> This article has been accepted for publication and undergone full peer review</note>

	<note type="copyright">but has not<lb/> been through the copyediting, typesetting, pagination and proofreading process, which may<lb/> lead to differences between this version and the Version of Record. Please cite this article as<lb/></note>

	<idno>doi: 10.1111/all.13307<lb/></idno>

	<note type="copyright">This article is protected by copyright. All rights reserved.<lb/></note>

	PROF. PHILIPPE DEVILLIER (Orcid ID : 0000-0003-4107-8317)<lb/> PROF. CRISTIANA STELLATO (Orcid ID :
	<idno>0000-0002-1294-8355</idno>

	)<lb/> Article type : Brief Communication<lb/> Editor<lb/> :
	<editor>Thomas Bieber<lb/></editor>

	<docTitle>
	<titlePart>The ARIA score of allergic rhinitis using mobile technology<lb/> correlates with quality-of-life: The MASK study<lb/></titlePart>
	</docTitle>

	<reference>J Bousquet, MD (1, 2), S Arnavielhe, PhD (3), A Bedbrook, BSc (1), J Fonseca, MD (4), M Morais<lb/> Almeida, MD (5), A Todo Bom, MD (6), I Annesi-Maesano, PhD (7), D Caimmi, MD (8), P Demoly, MD<lb/> (8), P Devillier, MD (9), V Siroux, PhD (10), E Menditto, PhD, (11), G Passalacqua, MD (12), C Stellato<lb/> ,MD (13), MT Ventura, MD (14), AA Cruz, MD (15), FS Serpa, MD, (16) J da Silva, MD, (17) D<lb/> Larenas-Linnemann, MD (18) M Rodriguez Gonzalez, MD, (19) MT Burguete Cabañas, MD, (20), KC<lb/> Bergmann, MD (21), T Keil, MD (22), L Klimek, MD (23), R Mösges, MD (24), S Shamai, MD, (24) T<lb/> Zuberbier, MD (21), M Bewick, MD, (25), D Price, MD (26), D Ryan, MD (27), A Sheikh, MD (28), JM<lb/> Anto, MD (29), J Mullol, MD (5), A Valero, MD (30), T Haahtela, MD (31), E Valovirta, MD (30), WJ<lb/> Fokkens MD, (32), P Kuna, MD (33), B Samolinski, MD, C Bindslev-Jensen, MD (34), E Eller, MD (34), S<lb/> Bosnic-Anticevich, PhD (35), RE O&apos;Hehir MD, (36), PV Tomazic, MD (37), A Yorgancioglu, MD, (38) B<lb/> Gemicioglu, MD, (39), C Bachert, MD (40), PW Hellings, MD (41), I Kull, PhD, (42), E Melén, MD (42),<lb/> M Wickman, MD (43), M van Eerd (44), G De Vries, PhD (44), and the MASK study group<lb/></reference>

	Accepted Article<lb/>
	<note type="copyright">This article is protected by copyright. All rights reserved.<lb/></note>

	<byline>
	<affiliation>30. Pneumology and Allergy Department Hospital Clínic, Clinical &amp; Experimental Respiratory Immunoallergy, IDIBAPS,<lb/> CIBERES, University of Barcelona,</affiliation>
	</byline>

	<address>Spain.<lb/></address>

	<byline>
	<affiliation>31. Skin and Allergy Hospital, Helsinki University Hospital,</affiliation>
	</byline>

	<address>Helsinki, Finland.<lb/></address>

	<byline>
	<affiliation>32. Department of Otorhinolaryngology, Academic Medical Centre,</affiliation>
	</byline>

	<address>Amsterdam, the Netherlands.<lb/></address>

	<byline>
	<affiliation>33. Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz,</affiliation>
	</byline>

	<address>Poland.<lb/></address>

	<byline>
	<affiliation>34. Department of Dermatology and Allergy Centre, Odense University Hospital, Odense Research Center for Anaphylaxis<lb/> (ORCA),</affiliation>
	</byline>

	<address>Odense, Denmark.<lb/></address>

	<byline>
	<affiliation>35. Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District,</affiliation>
	</byline>

	<address>Glebe, NSW,<lb/> Australia.<lb/></address>

	<byline>
	<affiliation>36. Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash<lb/> University,</affiliation>
	</byline>

	<address>Melbourne, Victoria, Australia;</address>

	<byline>
	<affiliation>Department of Immunology, Monash University,</affiliation>
	</byline>

	<address>Melbourne, Victoria,<lb/> Australia.<lb/></address>

	<byline>
	<affiliation>37. Department of ENT, Medical University of Graz,</affiliation>
	</byline>

	<address>Austria<lb/></address>

	<byline>
	<affiliation>38. Celal Bayar University Department of Pulmonology,</affiliation>
	</byline>

	<address>Manisa, Turkey and GARD Executive Committee, Turkey<lb/></address>

	<byline>
	<affiliation>39. Department of Pulmonary Diseases, Istanbul University, Cerrahpasa Faculty of Medicine,</affiliation>
	</byline>

	<address>Turkey.<lb/></address>

	<byline>
	<affiliation>40. Upper Airways Research Laboratory, ENT Dept, Ghent University Hospital,</affiliation>
	</byline>

	<address>Ghent, Belgium.<lb/></address>

	<byline>
	<affiliation>41. Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven,</affiliation>
	</byline>

	<address>Leuven, Belgium<lb/></address>

	<byline>
	<affiliation>42. Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet,</affiliation>
	</byline>

	<address>Stockholm, Sweden<lb/></address>

	<byline>
	<affiliation>43. Sachs&apos; Children and Youth Hospital, Södersjukhuset, Stockholm and Institute of Environmental Medicine, Karolinska<lb/> Institutet,</affiliation>
	</byline>

	<address>Stockholm, Sweden.<lb/></address>

	<byline>
	<affiliation>44. Peercode DV,</affiliation>
	</byline>

	<address>Gerdermalsen,The Netherlands.<lb/></address>

	Short title: Quality of life in rhinitis using a mobile application<lb/> Funding source<lb/>
	<note type="funding">Unrestricted educational grant from Meda, European Union Development and Structural funds<lb/> (Région Languedoc Roussillon), MACVIA-LR<lb/></note>

	Accepted Article<lb/>
	<note type="copyright">This article is protected by copyright. All rights reserved.<lb/></note>

	Corresponding author<lb/>
	<byline>
	<docAuthor>Professor Jean Bousquet<lb/></docAuthor>
	</byline>

	<byline>
	<affiliation>CHU Montpellier,</affiliation>
	</byline>

	<address>371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France Tel<lb/></address>

	+33 611 42 88 47
	<email>jean.bousquet@orange.fr</email>

	Abstract<lb/>
	<div type="abstract">Mobile technology has been used to appraise allergic rhinitis control but more data are needed. In<lb/> order to better assess the importance of mobile technologies in rhinitis control, the ARIA (Allergic<lb/> Rhinitis and its Impact on Asthma) score ranging from 0 to 4 of the Allergy Diary was compared with<lb/> EQ-5D (EuroQuol) and WPAI-AS (Work Productivity and Activity Impairment in allergy) in 1,288<lb/> users in 18 countries. This study showed that quality-of-life data (EQ-5D visual analogue scale and<lb/> WPA-IS Question 9) are similar in users without rhinitis and in those with mild rhinitis (scores 0-2).<lb/> Users with a score of 3 or 4 had a significant impairment in quality-of-life questionnaires.<lb/></div>

	Key words:
	<keyword>rhinitis, EQ-5D, ARIA, MASK, WPAI-AS</keyword>

	Abbreviations<lb/> AHA: Active and Healthy Aging<lb/> AR: allergic rhinitis<lb/> ARIA: Allergic Rhinitis and its Impact on Asthma<lb/> EIP on AHA: European Innovation Partnership on Active and Healthy Ageing (DG CONNECT, DG Santé)<lb/> EQ-5D: EuroQuol<lb/> ICT: information and communications technology<lb/> MACVIA: Contre les MAladies Chroniques pour un VIellissement Actif<lb/> MASK: MACVIA-ARIA Sentinel NetworK<lb/> MAFEIP: Monitoring and assessment framework for the EIP on AHA<lb/> QOL: Quality of life<lb/> Q9: Question 9 of WPAI-AS<lb/> SF-36: Short Form 36 questions<lb/> Accepted Article<lb/>
	<note type="copyright">This article is protected by copyright. All rights reserved.<lb/></note>

	VAS: visual analogue scale<lb/> WPAI-AS: Work Productivity and Activity Impairment in allergy
		</front>
	</text>
</tei>
